Evidence map›Paper›PMID 22608064›Full record

ArticleEpilepsy research2012

Variability of sclerosis along the longitudinal hippocampal axis in epilepsy: a post mortem study.

Maria Thom, Ioannis Liagkouras, Lillian Martinian, Joan Liu, Claudia B Catarino, Sanjay M Sisodiya

Open access · hybridAbstract read
In one paragraph

Article in Epilepsy research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Hippocampal sclerosis in feline epilepsy.Brain pathology (Zurich, Switzerland) · 2014
    Article
  17. Article
  18. Review: Hippocampal sclerosis in epilepsy: a neuropathology review.Neuropathology and applied neurobiology · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Maria ThomDepartment of Clinical and Experimental Epilepsy, UK. M.Thom@ion.ucl.ac.uk
Ioannis Liagkouras
Lillian Martinian
Joan Liu
Claudia B Catarino
Sanjay M Sisodiya
Epilepsy Research UK · GBNational Hospital for Neurology and Neurosurgery · GB

Funding

Department of HealthMedical Research Council 0600934Medical Research Council G0600934
6 · The paper itself

Abstract

Detailed neuropathological studies of the extent of hippocampal sclerosis (HS) in epilepsy along the longitudinal axis of the hippocampus are lacking. Neuroimaging studies of patients with temporal lobe epilepsy support that sclerosis is not always localised. The extent of HS is of relevance to surgical planning and poor outcomes may relate to residual HS in the posterior remnant. In 10 post mortems from patients with long histories of drug refractory epilepsy and 3 controls we systematically sampled the left and right hippocampus at seven coronal anatomical levels along the body to the tail. We quantified neuronal densities in CA1 and CA4 subfields at each level using Cresyl Violet (CV), calretinin (CR), calbindin (CB) and Neuropeptide Y (NPY) immunohistochemistry. In the dentate gyrus we graded the extent of granule cell dispersion, patterns of CB expression, and synaptic reorganisation with CR and NPY at each level. We identified four patterns of HS based on patterns of pyramidal and interneuronal loss and dentate gyrus reorganisation between sides and levels as follows: (1) symmetrical HS with anterior-posterior (AP) gradient, (2) symmetrical HS without AP gradient, (3) asymmetrical HS with AP gradient and (4) asymmetrical cases without AP gradient. We confirmed in this series that HS can extend into the tail. The patterns of sclerosis (classical versus atypical or none) were consistent between all levels in less than a third of cases. In conclusion, this series highlights the variability of HS along the longitudinal axis. Further studies are required to identify factors that lead to focal versus diffuse HS.

Indexed as

AdultAgedAged, 80 and overBenzoxazinesCA1 Region, HippocampalCalbindin 2CalbindinsCell CountColoring AgentsDentate GyrusEpilepsy, Temporal LobeFemaleHumansInterneuronsMaleMiddle AgedBenzoxazinesCALB2 protein, humanCalbindin 2CalbindinsColoring Agentscresyl violetNeuropeptide YOxazinesS100 Calcium Binding Protein G

Identifiers

PMID22608064
PMCPMC3500681
OpenAlexW2166918242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.